Breaking News

UNDBIO to Build $100M Insulin Manufacturing Facility in West Virginia

200 jobs will be created within the first three years of the project.

UNDBIO, a South Korean pharmaceutical company that provides diabetic care solutions, has secured a lease with West Virginia University to build an insulin manufacturing facility in Morgantown. The company will create 200 jobs within the first three years and will invest $100M in phase one of the project. “The mission of UNDBIO is to develop and produce state-of-the-art insulin in West Virginia,” said Caleb Jun, chairman, UNDBIO. “Our products will save human lives and improve the qua...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters